title: All-trans retinoic acid induces XAF1 expression through an interferon regulatory factor-1 element in colon cancer.
abstract: OBJECTIVE
  X-linked inhibitor of apoptosis protein (XIAP)-associated factor 1 (XAF1) is a novel tumor suppressor and interferon (IFN)-stimulated gene. All-trans retinoic acid (ATRA) exerts an antiproliferative effect on tumor cells through up-regulation of IFN regulatory factor 1 (IRF-1) and the downstream IFN-stimulated genes. The aim of this study was to determine the effect and mechanism of ATRA on XAF1 expression and the role of XAF1 in ATRA-induced growth inhibition in colon cancer.
  
  
  METHODS
  Gene expression is detected by reverse-transcription polymerase chain reaction and immunoblotting. The transcription activity of XAF1 promoter is examined by luciferase reporter assay. The activity of IFN regulatory factor binding element (IRF-E) is assessed by electrophoretic mobility shift assay and chromatin immunoprecipitation assay. Cell growth is evaluated by both in vitro and in vivo in nude mice xenografts.
  
  
  RESULTS
  IFN-alfa stimulates XAF1 promoter activity in the colon cancer cells Lovo and SW1116 dose-dependently. An IRF-1 binding element (IRF-E-XAF1) is found in the -30 to -38 nucleotide region upstream of the ATG initiator codon of the XAF1 gene. Site-directed mutagenesis of IRF-E-XAF1 abrogates native and IFN-induced promoter activity and binding capacity. ATRA induces XAF1 expression both in vitro and in vivo through interaction with IRF-E-XAF1. Overexpression of XAF1 increases cell susceptibility to ATRA-induced growth suppression both in vitro and in vivo. Furthermore, the effect of ATRA on XAF1 expression is independent of the promoter methylation and the subcellular distribution of XIAP.
  
  
  CONCLUSIONS
  XAF1 participates in ATRA-induced growth suppression through IRF-1-mediated transcriptional regulation.
authors.affiliation: Institute for Digestive Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
authors.forename: Jide
authors.initials: J
authors.lastname: Wang
authors.forename: Ying
authors.initials: Y
authors.lastname: Peng
authors.forename: Yun Wei
authors.initials: YW
authors.lastname: Sun
authors.forename: Hua
authors.initials: H
authors.lastname: He
authors.forename: Senlin
authors.initials: S
authors.lastname: Zhu
authors.forename: Xiaomeng
authors.initials: X
authors.lastname: An
authors.forename: Ming
authors.initials: M
authors.lastname: Li
authors.forename: Marie C M
authors.initials: MC
authors.lastname: Lin
authors.forename: Bing
authors.initials: B
authors.lastname: Zou
authors.forename: Harry Hua-Xiang
authors.initials: HH
authors.lastname: Xia
authors.forename: Bo
authors.initials: B
authors.lastname: Jiang
authors.forename: Annie O O
authors.initials: AO
authors.lastname: Chan
authors.forename: Man Fung
authors.initials: MF
authors.lastname: Yuen
authors.forename: Hsiang Fu
authors.initials: HF
authors.lastname: Kung
authors.forename: Benjamin C Y
authors.initials: BC
authors.lastname: Wong
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D000818:Animals; D051017:Apoptosis Regulatory Proteins; D045744:Cell Line, Tumor; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D018899:CpG Islands; D019175:DNA Methylation; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D050856:Interferon Regulatory Factor-1 / Q000502:physiology*; D047908:Intracellular Signaling Peptides and Proteins; D051379:Mice; D016297:Mutagenesis, Site-Directed; D009363:Neoplasm Proteins / Q000235:genetics* / Q000502:physiology; D011401:Promoter Regions, Genetic; D024363:Transcription Initiation Site; D014212:Tretinoin / Q000494:pharmacology*
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D051017:Apoptosis Regulatory Proteins; D050856:Interferon Regulatory Factor-1; D047908:Intracellular Signaling Peptides and Proteins; D009363:Neoplasm Proteins; C417551:XAF1 protein, human; D014212:Tretinoin